Hormonal Effects on Gastrointestinal Cancer Growth
Carcinomas of the gastrointestinal (GI) tract and pancreas account for more than 150000 new cases of cancer and cause the death of 75000 patients yearly in the United States (Silverberg and Lubera, 1988). Treatment of patients with these cancers relies heavily on adequate surgical resection. This is effective only when localized tumor is present. There is no effective systemic treatment for metastatic colon, stomach or pancreatic cancer.
Unable to display preview. Download preview PDF.
- Alexander, R.W., Upp, J.R., Jr, Singh, P., Hugh, T., Poston, G.J., Townsend, C.M., Jr and Thompson, J.C. (1987). Asperlicin inhibits the growth of a xenografted human pancreatic carcinoma. Gastroenterology, 92, 1293 (abst.).Google Scholar
- Evers, B.M., Gomez, G., Townsend, C.M., Jr, Uchida, T., Singh, P. and Thompson, J.C. (1989b). Enprostil inhibits the growth of a human gastric adenocarcinoma. Gastroenterology, in press.Google Scholar
- Milhoan, R.A., Trudel, J.L., Lawrence, J.P., Townsend, C.M., Jr and Thompson, J.C. (1988). Somatostatin inhibits growth of human small cell lung carcinoma in vivo. Surg. Forum, 39, 438–9.Google Scholar
- Silverberg, E. and Lubera, J.A. (1988). Cancer statistics, 1988. Ca-A, 38, 5–22.Google Scholar
- Takahashi, T., Yamaguchi, T., Bando, K., Tanaka, J., Ogata, B.N. and Kohno, K. (1982). Effects of gastrointestinal hormones on protein synthesis and growth of gastrointestinal cancers (abstract booklet). International Cancer Congress, 97.Google Scholar
- Townsend, C.M., Jr, Franklin, R.B., Watson, L.C., Glass, E.J. and Thompson, J.C. (1981). Stimulation of pancreatic cancer growth by caerulein and secretin. Surg. Forum., 32, 228–9.Google Scholar
- Trudel, J.L., Lawrence, J.P., Milhoan, R.A., Townsend, C.M., Jr and Thompson, J.C. (1988). The effect of gastrin on the growth of three human colon carcinomas xenografted in nude mice. Biomed. Res., 9, 111.Google Scholar
- Upp, J.R., Jr, Singh, P., Townsend, C.M., Jr and Thompson, J.C. (1987b). Predicting response to endocrine therapy in human pancreatic cancer with cholecystokinin receptors. Gastroenterology, 92, 1677 (abstr.).Google Scholar